Non Alcoholic Fatty Liver Disease
Conditions
Brief summary
The purpose of this study is to assess UDFF performance (compared to MRI)
Interventions
DIAGNOSTIC_TESTUDFF
quantification of liver fat: UDFF (lipid fraction derived from ultrasound) from one of the probes of an ultrasound system
Sponsors
University Hospital, Angers
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients who had hepatic ultrasound with available UDFF measurements and hepatic MRI (with steatosis quantification sequences) between 01/01/2022 and 31/09/2023 may be included.
Exclusion criteria
* chronic liver disease with a different etiology other than NAFL/NASH or mixed (hepatitis B or C, hemochromatosis, autoimmune hepatitis, Wilson's disease, cholestasic disease, alpha 1 antitrypsin deficiency), * decompensated cirrhosis (ascites, jaundice, encephalopathy, rupture of esophageal varices), * hepatocellular carcinoma. * opposition to the use of its data
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To evaluate the perfomances of the UDFF system for the quantification of hepatic steatosis in patients suspected of chronic hepatophyte. | 3 months maximum between the 2 measurements (UDFF and MRi) | Steatosis value measured by multiecho sequences in MR |
Countries
France
Contacts
Primary ContactChristophe Aubé
Backup ContactMarie Bost
Outcome results
None listed